Retrospective Real-Life Comparison of Obinutuzumab Plus Chlorambucil Versus Ibrutinib in Previously Untreated and Unfit Patients with Chronic Lymphocytic Leukemia without TP53 Disruptions. Interim Results from the Italian CLL Campus

Visentin, A; Mauro, FR; Pietrasanta, D; Fresa, A; Vitale, C; Ciolli, S; Cassin, R; Cibien, F; Sportoletti, P; Gentile, M; Rigolin, GM; Quaglia, FM; Murru, R; Gozzetti, A; Molica, S; Marchetti, M; Scarfo, L; Reda, G; Coscia, M; Laurenti, L; Pizzolo, G; Semenzato, G; Foa, R; Cuneo, A; Trentin, L

BLOOD, 2020; 136 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索